Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Similar articles for PubMed (Select 22925313)

1.

Neoadjuvant chemoradiotherapy followed by esophagectomy does not increase morbidity in patients over 70.

Blom RL, van Heijl M, Klinkenbijl JH, Bergman JJ, Wilmink JW, Richel DJ, Hulshof MC, Reitsma JB, Busch OR, van Berge Henegouwen MI.

Dis Esophagus. 2013 Jul;26(5):510-6. doi: 10.1111/j.1442-2050.2012.01394.x. Epub 2012 Aug 23.

PMID:
22925313
2.

Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma.

Blom RL, Sosef MN, Nap M, Lammering G, van den Berkmortel F, Hulshof MC, Meijer SL, Wilmink HW, van Berge Henegouwen MI.

Dis Esophagus. 2014 May-Jun;27(4):380-7. doi: 10.1111/dote.12110. Epub 2013 Sep 5.

PMID:
24006852
3.

Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer.

Chang KJ, Reid T, Senzer N, Swisher S, Pinto H, Hanna N, Chak A, Soetikno R.

Gastrointest Endosc. 2012 Jun;75(6):1139-46.e2. doi: 10.1016/j.gie.2012.01.042. Epub 2012 Apr 18.

PMID:
22520270
4.

Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.

Bosch DJ, Muijs CT, Mul VE, Beukema JC, Hospers GA, Burgerhof JG, Plukker JT.

Ann Surg Oncol. 2014 Feb;21(2):605-11. doi: 10.1245/s10434-013-3316-8. Epub 2013 Oct 8.

PMID:
24100962
5.

Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.

Smit JK, G├╝ler S, Beukema JC, Mul VE, Burgerhof JG, Hospers GA, Plukker JT.

Ann Surg Oncol. 2013 Nov;20(12):4008-15. doi: 10.1245/s10434-013-3102-7. Epub 2013 Jul 10.

PMID:
23838922
6.

Neoadjuvant chemoradiotherapy for esophageal carcinoma.

Zhang X, Watson DI, Jamieson GG, Bessell JR, Devitt PG.

Dis Esophagus. 2005;18(2):104-8.

PMID:
16053485
7.

Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.

Gerber N, Ilson DH, Wu AJ, Janjigian YY, Kelsen DP, Zheng J, Zhang Z, Bains MS, Rizk N, Rusch VW, Goodman KA.

Dis Esophagus. 2014 Apr;27(3):235-41. doi: 10.1111/dote.12082. Epub 2013 Jun 24.

PMID:
23796070
8.

Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.

Ruol A, Portale G, Castoro C, Merigliano S, Cagol M, Cavallin F, Chiarion Sileni V, Corti L, Rampado S, Costantini M, Ancona E.

Ann Surg Oncol. 2007 Nov;14(11):3243-50. Epub 2007 Aug 23.

PMID:
17713823
9.

Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.

Hoeppner J, Zirlik K, Brunner T, Bronsert P, Kulemann B, Sick O, Marjanovic G, Hopt UT, Makowiec F.

J Surg Oncol. 2014 Mar;109(3):287-93. doi: 10.1002/jso.23498. Epub 2013 Nov 26.

PMID:
24277235
10.

Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy.

Kelley ST, Coppola D, Karl RC.

J Gastrointest Surg. 2004 Mar-Apr;8(3):227-31; discussion 231-2.

PMID:
15019913
11.

Adenocarcinoma of the esophagus and esophagogastric junction in patients older than 70 years: results of neoadjuvant radiochemotherapy followed by transthoracic esophagectomy.

Camerlo A, D'Journo XB, Ouattara M, Trousse D, Doddoli C, Thomas PA.

J Visc Surg. 2012 Jun;149(3):e203-10. doi: 10.1016/j.jviscsurg.2012.03.006. Epub 2012 May 23.

PMID:
22633088
12.

Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?

Hsu PK, Chien LI, Huang CS, Hsieh CC, Wu YC, Hsu WH, Chou TY.

Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):460-6. doi: 10.1093/icvts/ivt216. Epub 2013 May 31.

13.

Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.

Vermund H, Pories WJ, Hillard J, Wiley AL, Youngblood R.

Acta Oncol. 2001;40(5):558-65. Review.

PMID:
11669326
14.

Complete clinical response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic oesophagus: is surgery always necessary?

Castoro C, Scarpa M, Cagol M, Alfieri R, Ruol A, Cavallin F, Michieletto S, Zanchettin G, Chiarion-Sileni V, Corti L, Ancona E.

J Gastrointest Surg. 2013 Aug;17(8):1375-81.

PMID:
23797888
15.

Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer.

Berger AC, Scott WJ, Freedman G, Konski A, Weiner L, Cheng JD, Goldberg M.

Semin Oncol. 2005 Dec;32(6 Suppl 9):S16-20.

PMID:
16399424
16.

Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center.

Zanoni A, Verlato G, Giacopuzzi S, Weindelmayer J, Casella F, Pasini F, Zhao E, de Manzoni G.

Ann Surg Oncol. 2013 Jun;20(6):1993-9. doi: 10.1245/s10434-012-2822-4. Epub 2012 Dec 29.

PMID:
23274533
17.

Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.

Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E.

Ann Surg Oncol. 2011 Dec;18(13):3743-54. doi: 10.1245/s10434-011-1753-9. Epub 2011 May 10.

PMID:
21556952
18.

Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.

Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB Jr, Komaki R, Ajani JA, Roth JA.

Ann Thorac Surg. 2005 Feb;79(2):391-7; discussionn 391-7.

PMID:
15680801
19.

Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.

Chidel MA, Rice TW, Adelstein DJ, Kupelian PA, Suh JH, Becker M.

Radiology. 1999 Oct;213(1):67-72.

PMID:
10540642
20.

Evaluation of progression prior to surgery after neoadjuvant chemoradiotherapy with computed tomography in esophageal cancer patients.

Hulshoff JB, Smit JK, van der Jagt EJ, Plukker JT.

Am J Surg. 2014 Jul;208(1):73-9. doi: 10.1016/j.amjsurg.2013.08.048. Epub 2014 Jan 4.

PMID:
24476969
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk